vs
Side-by-side financial comparison of Hubbell Incorporated (HUBB) and Organon & Co. (OGN). Click either name above to swap in a different company.
Hubbell Incorporated is the larger business by last-quarter revenue ($1.5B vs $1.5B, roughly 1.0× Organon & Co.). Hubbell Incorporated runs the higher net margin — 14.6% vs 10.0%, a 4.6% gap on every dollar of revenue. On growth, Hubbell Incorporated posted the faster year-over-year revenue change (11.9% vs -3.5%). Over the past eight quarters, Hubbell Incorporated's revenue compounded faster (3.3% CAGR vs -4.7%).
Hubbell Incorporated, headquartered in Shelton, Connecticut, is an American company that designs, manufactures, and sells electrical and electronic products for non-residential and residential construction, industrial, and utility applications. Hubbell was founded by Harvey Hubbell as a proprietorship in 1888, and was incorporated in Connecticut in 1905.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
HUBB vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.5B |
| Net Profit | $217.7M | $146.0M |
| Gross Margin | 34.6% | 53.6% |
| Operating Margin | 20.3% | — |
| Net Margin | 14.6% | 10.0% |
| Revenue YoY | 11.9% | -3.5% |
| Net Profit YoY | 10.5% | 67.8% |
| EPS (diluted) | $4.06 | $0.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.5B | ||
| Q4 25 | $1.5B | $1.5B | ||
| Q3 25 | $1.5B | $1.6B | ||
| Q2 25 | $1.5B | $1.6B | ||
| Q1 25 | $1.4B | $1.5B | ||
| Q4 24 | $1.3B | $1.6B | ||
| Q3 24 | $1.4B | $1.6B | ||
| Q2 24 | $1.5B | $1.6B |
| Q1 26 | — | $146.0M | ||
| Q4 25 | $217.7M | $-205.0M | ||
| Q3 25 | $255.5M | $160.0M | ||
| Q2 25 | $244.2M | $145.0M | ||
| Q1 25 | $169.7M | $87.0M | ||
| Q4 24 | $197.0M | $109.0M | ||
| Q3 24 | $219.4M | $359.0M | ||
| Q2 24 | $213.6M | $195.0M |
| Q1 26 | — | 53.6% | ||
| Q4 25 | 34.6% | 49.2% | ||
| Q3 25 | 36.2% | 53.5% | ||
| Q2 25 | 37.2% | 54.8% | ||
| Q1 25 | 33.1% | 55.6% | ||
| Q4 24 | 33.8% | 56.3% | ||
| Q3 24 | 34.5% | 58.3% | ||
| Q2 24 | 35.0% | 58.4% |
| Q1 26 | — | — | ||
| Q4 25 | 20.3% | -9.8% | ||
| Q3 25 | 22.0% | 15.2% | ||
| Q2 25 | 22.7% | 14.4% | ||
| Q1 25 | 17.5% | 6.7% | ||
| Q4 24 | 19.3% | 8.1% | ||
| Q3 24 | 21.1% | 13.1% | ||
| Q2 24 | 20.7% | 14.6% |
| Q1 26 | — | 10.0% | ||
| Q4 25 | 14.6% | -13.6% | ||
| Q3 25 | 17.0% | 10.0% | ||
| Q2 25 | 16.5% | 9.1% | ||
| Q1 25 | 12.4% | 5.8% | ||
| Q4 24 | 14.8% | 6.8% | ||
| Q3 24 | 15.2% | 22.7% | ||
| Q2 24 | 14.7% | 12.1% |
| Q1 26 | — | $0.55 | ||
| Q4 25 | $4.06 | $-0.78 | ||
| Q3 25 | $4.77 | $0.61 | ||
| Q2 25 | $4.56 | $0.56 | ||
| Q1 25 | $3.15 | $0.33 | ||
| Q4 24 | $3.65 | $0.42 | ||
| Q3 24 | $4.05 | $1.38 | ||
| Q2 24 | $3.94 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $497.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.8B | — |
| Total Assets | $8.2B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $497.9M | $574.0M | ||
| Q3 25 | $680.9M | $672.0M | ||
| Q2 25 | $399.6M | $599.0M | ||
| Q1 25 | $360.3M | $547.0M | ||
| Q4 24 | $345.0M | $675.0M | ||
| Q3 24 | $445.6M | $763.0M | ||
| Q2 24 | $406.5M | $704.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $8.6B | ||
| Q3 25 | $1.4B | $8.8B | ||
| Q2 25 | $1.4B | $8.9B | ||
| Q1 25 | $1.4B | $9.0B | ||
| Q4 24 | $1.4B | $8.9B | ||
| Q3 24 | $1.7B | $8.7B | ||
| Q2 24 | $1.9B | $8.7B |
| Q1 26 | — | — | ||
| Q4 25 | $3.8B | $752.0M | ||
| Q3 25 | $3.7B | $906.0M | ||
| Q2 25 | $3.5B | $733.0M | ||
| Q1 25 | $3.3B | $542.0M | ||
| Q4 24 | $3.3B | $472.0M | ||
| Q3 24 | $3.2B | $493.0M | ||
| Q2 24 | $3.1B | $144.0M |
| Q1 26 | — | — | ||
| Q4 25 | $8.2B | $12.9B | ||
| Q3 25 | $7.5B | $13.6B | ||
| Q2 25 | $7.1B | $13.5B | ||
| Q1 25 | $6.9B | $13.2B | ||
| Q4 24 | $6.7B | $13.1B | ||
| Q3 24 | $6.9B | $12.8B | ||
| Q2 24 | $6.9B | $12.2B |
| Q1 26 | — | — | ||
| Q4 25 | — | 11.49× | ||
| Q3 25 | 0.39× | 9.74× | ||
| Q2 25 | 0.41× | 12.14× | ||
| Q1 25 | 0.44× | 16.52× | ||
| Q4 24 | 0.44× | 18.81× | ||
| Q3 24 | 0.51× | 17.75× | ||
| Q2 24 | 0.63× | 60.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $447.5M | — |
| Free Cash FlowOCF − Capex | $388.8M | — |
| FCF MarginFCF / Revenue | 26.0% | — |
| Capex IntensityCapex / Revenue | 3.9% | — |
| Cash ConversionOCF / Net Profit | 2.06× | — |
| TTM Free Cash FlowTrailing 4 quarters | $874.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $447.5M | $141.0M | ||
| Q3 25 | $284.3M | $264.0M | ||
| Q2 25 | $260.6M | $220.0M | ||
| Q1 25 | $37.4M | $75.0M | ||
| Q4 24 | $432.4M | $390.0M | ||
| Q3 24 | $227.0M | $141.0M | ||
| Q2 24 | $239.6M | $332.0M |
| Q1 26 | — | — | ||
| Q4 25 | $388.8M | $96.0M | ||
| Q3 25 | $253.8M | $218.0M | ||
| Q2 25 | $220.7M | $181.0M | ||
| Q1 25 | $11.4M | $43.0M | ||
| Q4 24 | $364.4M | $335.0M | ||
| Q3 24 | $188.8M | $99.0M | ||
| Q2 24 | $205.7M | $300.0M |
| Q1 26 | — | — | ||
| Q4 25 | 26.0% | 6.4% | ||
| Q3 25 | 16.9% | 13.6% | ||
| Q2 25 | 14.9% | 11.4% | ||
| Q1 25 | 0.8% | 2.8% | ||
| Q4 24 | 27.3% | 21.0% | ||
| Q3 24 | 13.1% | 6.3% | ||
| Q2 24 | 14.2% | 18.7% |
| Q1 26 | — | — | ||
| Q4 25 | 3.9% | 3.0% | ||
| Q3 25 | 2.0% | 2.9% | ||
| Q2 25 | 2.7% | 2.4% | ||
| Q1 25 | 1.9% | 2.1% | ||
| Q4 24 | 5.1% | 3.5% | ||
| Q3 24 | 2.6% | 2.7% | ||
| Q2 24 | 2.3% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 2.06× | — | ||
| Q3 25 | 1.11× | 1.65× | ||
| Q2 25 | 1.07× | 1.52× | ||
| Q1 25 | 0.22× | 0.86× | ||
| Q4 24 | 2.19× | 3.58× | ||
| Q3 24 | 1.03× | 0.39× | ||
| Q2 24 | 1.12× | 1.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HUBB
| Grid Infrastructure | $717.0M | 48% |
| Industrial | $393.7M | 26% |
| Grid Automation | $218.9M | 15% |
| Electrical Products | $163.1M | 11% |
OGN
| Established Brands | $880.0M | 60% |
| Women’s Health | $389.0M | 27% |
| Biosimilars | $173.0M | 12% |
